Concepts (280)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hip Fractures | 40 | 2023 | 966 | 10.890 |
Why?
|
Nursing Homes | 51 | 2024 | 1049 | 9.820 |
Why?
|
Accidental Falls | 27 | 2024 | 1035 | 4.500 |
Why?
|
Homes for the Aged | 13 | 2021 | 265 | 3.770 |
Why?
|
Osteoporosis | 15 | 2022 | 1581 | 3.470 |
Why?
|
Bone Density Conservation Agents | 11 | 2022 | 779 | 3.380 |
Why?
|
Frail Elderly | 12 | 2023 | 719 | 2.800 |
Why?
|
Skilled Nursing Facilities | 9 | 2023 | 390 | 2.440 |
Why?
|
Nursing Staff | 3 | 2023 | 123 | 2.240 |
Why?
|
Osteoporotic Fractures | 8 | 2023 | 397 | 2.220 |
Why?
|
Long-Term Care | 8 | 2023 | 616 | 1.790 |
Why?
|
Diphosphonates | 5 | 2020 | 626 | 1.580 |
Why?
|
Medicare | 29 | 2024 | 6555 | 1.530 |
Why?
|
Fractures, Bone | 8 | 2022 | 2010 | 1.270 |
Why?
|
Aged, 80 and over | 52 | 2024 | 57586 | 1.090 |
Why?
|
Hypnotics and Sedatives | 4 | 2019 | 1160 | 0.950 |
Why?
|
Aged | 73 | 2024 | 164383 | 0.930 |
Why?
|
Geriatric Assessment | 6 | 2020 | 1367 | 0.860 |
Why?
|
Dementia | 6 | 2022 | 2546 | 0.840 |
Why?
|
Activities of Daily Living | 8 | 2023 | 2381 | 0.830 |
Why?
|
Hospitalization | 9 | 2023 | 10333 | 0.820 |
Why?
|
Independent Living | 4 | 2024 | 558 | 0.810 |
Why?
|
Bone Density | 7 | 2023 | 3511 | 0.800 |
Why?
|
United States | 40 | 2024 | 70437 | 0.790 |
Why?
|
Antihypertensive Agents | 3 | 2023 | 2044 | 0.780 |
Why?
|
Hypoglycemia | 3 | 2024 | 845 | 0.770 |
Why?
|
Allied Health Personnel | 2 | 2022 | 156 | 0.750 |
Why?
|
Retrospective Studies | 33 | 2023 | 78313 | 0.640 |
Why?
|
Vaccination | 6 | 2023 | 3283 | 0.640 |
Why?
|
Terminal Care | 2 | 2021 | 1725 | 0.640 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2021 | 1218 | 0.640 |
Why?
|
Disabled Persons | 2 | 2018 | 1191 | 0.620 |
Why?
|
Risk Assessment | 14 | 2024 | 23464 | 0.610 |
Why?
|
Wounds and Injuries | 4 | 2020 | 2410 | 0.600 |
Why?
|
Female | 71 | 2024 | 382450 | 0.600 |
Why?
|
Humans | 107 | 2024 | 746630 | 0.590 |
Why?
|
Male | 64 | 2024 | 351420 | 0.590 |
Why?
|
Pelvic Bones | 1 | 2019 | 269 | 0.580 |
Why?
|
Risk Management | 1 | 2020 | 556 | 0.570 |
Why?
|
Drug Utilization Review | 1 | 2017 | 246 | 0.550 |
Why?
|
Health Services for the Aged | 1 | 2018 | 255 | 0.530 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 740 | 0.490 |
Why?
|
Perception | 1 | 2021 | 1179 | 0.490 |
Why?
|
Quality Improvement | 2 | 2021 | 3739 | 0.480 |
Why?
|
Risk Factors | 28 | 2024 | 72447 | 0.480 |
Why?
|
Drug Prescriptions | 2 | 2013 | 1644 | 0.460 |
Why?
|
Advance Care Planning | 1 | 2021 | 676 | 0.450 |
Why?
|
Disease Outbreaks | 2 | 2022 | 1730 | 0.430 |
Why?
|
Child Health Services | 1 | 2018 | 655 | 0.420 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2024 | 11966 | 0.420 |
Why?
|
Sulfonylurea Compounds | 3 | 2023 | 217 | 0.420 |
Why?
|
Checklist | 1 | 2018 | 807 | 0.390 |
Why?
|
Cross-Over Studies | 5 | 2017 | 2015 | 0.390 |
Why?
|
Cohort Studies | 15 | 2023 | 40534 | 0.390 |
Why?
|
Postural Balance | 4 | 2024 | 607 | 0.380 |
Why?
|
Sodium Potassium Chloride Symporter Inhibitors | 1 | 2012 | 136 | 0.370 |
Why?
|
Lower Extremity | 1 | 2019 | 1176 | 0.370 |
Why?
|
Analgesics | 1 | 2017 | 1020 | 0.370 |
Why?
|
Alendronate | 2 | 2018 | 174 | 0.360 |
Why?
|
Memantine | 1 | 2011 | 106 | 0.360 |
Why?
|
Dopamine Agents | 1 | 2011 | 189 | 0.360 |
Why?
|
Nootropic Agents | 1 | 2011 | 155 | 0.350 |
Why?
|
Health Promotion | 1 | 2022 | 2190 | 0.340 |
Why?
|
Cholinesterase Inhibitors | 1 | 2011 | 237 | 0.340 |
Why?
|
Benzodiazepines | 1 | 2015 | 1114 | 0.330 |
Why?
|
Diuretics | 1 | 2012 | 581 | 0.330 |
Why?
|
Patient-Centered Care | 1 | 2018 | 1399 | 0.310 |
Why?
|
Syncope | 1 | 2011 | 422 | 0.310 |
Why?
|
Absorptiometry, Photon | 5 | 2023 | 1736 | 0.310 |
Why?
|
Teriparatide | 2 | 2021 | 223 | 0.300 |
Why?
|
Pain, Postoperative | 1 | 2017 | 1658 | 0.300 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 2 | 2021 | 306 | 0.290 |
Why?
|
Influenza, Human | 1 | 2018 | 1503 | 0.290 |
Why?
|
Psychotropic Drugs | 1 | 2013 | 879 | 0.290 |
Why?
|
Intensive Care Units | 1 | 2019 | 3674 | 0.270 |
Why?
|
Subacute Care | 3 | 2023 | 180 | 0.270 |
Why?
|
Incidence | 9 | 2020 | 20820 | 0.270 |
Why?
|
Pandemics | 5 | 2023 | 8443 | 0.260 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14124 | 0.250 |
Why?
|
Osteoporosis, Postmenopausal | 2 | 2018 | 391 | 0.240 |
Why?
|
Thiazides | 1 | 2023 | 19 | 0.230 |
Why?
|
Myocardial Infarction | 2 | 2022 | 11658 | 0.230 |
Why?
|
Age Factors | 6 | 2020 | 18157 | 0.230 |
Why?
|
Stroke | 2 | 2023 | 9693 | 0.230 |
Why?
|
Amlodipine | 1 | 2023 | 80 | 0.230 |
Why?
|
Hypertension | 1 | 2023 | 8366 | 0.230 |
Why?
|
Femur Neck | 2 | 2018 | 307 | 0.220 |
Why?
|
Vaccines | 2 | 2022 | 817 | 0.220 |
Why?
|
Multiple Sclerosis | 1 | 2018 | 3132 | 0.220 |
Why?
|
Geriatrics | 3 | 2019 | 385 | 0.220 |
Why?
|
Glipizide | 1 | 2022 | 43 | 0.210 |
Why?
|
Antidepressive Agents | 2 | 2013 | 2867 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3057 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3169 | 0.210 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2017 | 10750 | 0.210 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2023 | 1510 | 0.200 |
Why?
|
Glyburide | 1 | 2022 | 106 | 0.200 |
Why?
|
Hypoglycemic Agents | 3 | 2024 | 3031 | 0.200 |
Why?
|
Antipsychotic Agents | 1 | 2015 | 3053 | 0.200 |
Why?
|
Assisted Living Facilities | 1 | 2021 | 25 | 0.200 |
Why?
|
Medication Adherence | 2 | 2010 | 2113 | 0.200 |
Why?
|
Analgesics, Opioid | 3 | 2024 | 3678 | 0.200 |
Why?
|
Pharmaceutical Services | 1 | 2023 | 141 | 0.190 |
Why?
|
Pharmacy | 1 | 2023 | 92 | 0.190 |
Why?
|
Pharmacies | 1 | 2023 | 158 | 0.190 |
Why?
|
Length of Stay | 2 | 2024 | 6293 | 0.180 |
Why?
|
Age Distribution | 3 | 2017 | 2842 | 0.180 |
Why?
|
Hearing Aids | 1 | 2020 | 57 | 0.170 |
Why?
|
Sex Factors | 4 | 2019 | 10284 | 0.170 |
Why?
|
Kaplan-Meier Estimate | 1 | 2010 | 6460 | 0.170 |
Why?
|
Heart Failure | 1 | 2023 | 11096 | 0.170 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2019 | 170 | 0.160 |
Why?
|
Meta-Analysis as Topic | 1 | 2024 | 1357 | 0.160 |
Why?
|
Comorbidity | 4 | 2019 | 10372 | 0.160 |
Why?
|
Logistic Models | 4 | 2017 | 13170 | 0.160 |
Why?
|
Resistance Training | 1 | 2021 | 174 | 0.160 |
Why?
|
Time Factors | 6 | 2019 | 39622 | 0.160 |
Why?
|
Sex Distribution | 2 | 2017 | 2259 | 0.160 |
Why?
|
Pneumonia, Aspiration | 1 | 2019 | 147 | 0.160 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12021 | 0.160 |
Why?
|
Medicare Part D | 1 | 2023 | 335 | 0.160 |
Why?
|
Life Expectancy | 2 | 2019 | 1223 | 0.160 |
Why?
|
Cholinergic Antagonists | 1 | 2019 | 164 | 0.160 |
Why?
|
Odds Ratio | 3 | 2019 | 9599 | 0.160 |
Why?
|
Cardiovascular Diseases | 1 | 2024 | 15319 | 0.160 |
Why?
|
New Hampshire | 1 | 2018 | 173 | 0.160 |
Why?
|
Dehydration | 1 | 2019 | 229 | 0.150 |
Why?
|
Policy | 1 | 2022 | 503 | 0.150 |
Why?
|
Soft Tissue Injuries | 1 | 2019 | 172 | 0.150 |
Why?
|
Irritable Bowel Syndrome | 1 | 2023 | 451 | 0.150 |
Why?
|
Communication | 3 | 2022 | 3792 | 0.150 |
Why?
|
Calcitonin | 1 | 2018 | 329 | 0.150 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12280 | 0.140 |
Why?
|
Cognition Disorders | 1 | 2011 | 3958 | 0.140 |
Why?
|
Calibration | 1 | 2019 | 801 | 0.140 |
Why?
|
Obesity | 1 | 2019 | 12728 | 0.140 |
Why?
|
Patient Acceptance of Health Care | 1 | 2010 | 3067 | 0.140 |
Why?
|
Boston | 3 | 2022 | 9213 | 0.130 |
Why?
|
Middle Aged | 11 | 2024 | 214618 | 0.130 |
Why?
|
Follow-Up Studies | 6 | 2017 | 38771 | 0.130 |
Why?
|
New Zealand | 3 | 2021 | 352 | 0.130 |
Why?
|
HIV Infections | 1 | 2021 | 16936 | 0.120 |
Why?
|
Aging | 3 | 2022 | 8486 | 0.120 |
Why?
|
Models, Economic | 1 | 2019 | 717 | 0.120 |
Why?
|
Reward | 1 | 2021 | 935 | 0.120 |
Why?
|
Influenza Vaccines | 1 | 2022 | 745 | 0.120 |
Why?
|
Mobility Limitation | 1 | 2019 | 402 | 0.120 |
Why?
|
Sarcopenia | 1 | 2019 | 363 | 0.120 |
Why?
|
Documentation | 1 | 2021 | 876 | 0.120 |
Why?
|
Biomedical Research | 1 | 2010 | 3328 | 0.120 |
Why?
|
Peer Group | 1 | 2019 | 650 | 0.120 |
Why?
|
Home Care Services | 2 | 2019 | 625 | 0.120 |
Why?
|
Geography | 1 | 2016 | 653 | 0.120 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 4586 | 0.120 |
Why?
|
Renal Insufficiency | 1 | 2019 | 787 | 0.120 |
Why?
|
Prognosis | 3 | 2019 | 29079 | 0.110 |
Why?
|
Pneumonia | 2 | 2019 | 2116 | 0.110 |
Why?
|
Health Personnel | 3 | 2022 | 3225 | 0.110 |
Why?
|
Moving and Lifting Patients | 1 | 2013 | 18 | 0.110 |
Why?
|
Urinary Tract Infections | 1 | 2019 | 801 | 0.110 |
Why?
|
Hearing Loss | 1 | 2020 | 734 | 0.110 |
Why?
|
Case-Control Studies | 2 | 2021 | 21693 | 0.110 |
Why?
|
Massachusetts | 3 | 2017 | 8609 | 0.100 |
Why?
|
Hospice Care | 1 | 2019 | 684 | 0.100 |
Why?
|
Sodium Chloride Symporter Inhibitors | 1 | 2012 | 71 | 0.100 |
Why?
|
Emergency Medical Services | 1 | 2024 | 1887 | 0.100 |
Why?
|
Interprofessional Relations | 1 | 2018 | 1000 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10096 | 0.100 |
Why?
|
Acute Kidney Injury | 1 | 2024 | 1847 | 0.100 |
Why?
|
Fee-for-Service Plans | 1 | 2017 | 684 | 0.100 |
Why?
|
Motivation | 1 | 2021 | 1966 | 0.100 |
Why?
|
Administration, Oral | 2 | 2023 | 3978 | 0.090 |
Why?
|
Health Status Disparities | 2 | 2020 | 1764 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 1088 | 0.090 |
Why?
|
Neoplasms | 1 | 2019 | 21715 | 0.090 |
Why?
|
Acute Disease | 2 | 2012 | 7124 | 0.090 |
Why?
|
Refusal to Participate | 1 | 2010 | 25 | 0.090 |
Why?
|
Survival Rate | 2 | 2018 | 12645 | 0.090 |
Why?
|
Epidemiologic Methods | 2 | 2012 | 1337 | 0.090 |
Why?
|
Testosterone | 1 | 2021 | 2439 | 0.090 |
Why?
|
Vaccines, Synthetic | 2 | 2022 | 600 | 0.080 |
Why?
|
Internet | 1 | 2021 | 3039 | 0.080 |
Why?
|
Outpatients | 1 | 2017 | 1553 | 0.080 |
Why?
|
Pilot Projects | 2 | 2019 | 8378 | 0.080 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4883 | 0.080 |
Why?
|
Recurrence | 3 | 2012 | 8384 | 0.080 |
Why?
|
Rehabilitation Centers | 1 | 2010 | 246 | 0.080 |
Why?
|
Population Surveillance | 1 | 2019 | 2587 | 0.080 |
Why?
|
Patient Discharge | 2 | 2023 | 3314 | 0.080 |
Why?
|
Hospitals | 1 | 2021 | 3855 | 0.080 |
Why?
|
Pressure Ulcer | 1 | 2009 | 153 | 0.080 |
Why?
|
Psychological Tests | 1 | 2010 | 638 | 0.070 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2011 | 481 | 0.070 |
Why?
|
Exercise | 1 | 2024 | 5688 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2019 | 2289 | 0.070 |
Why?
|
Treatment Outcome | 3 | 2024 | 63732 | 0.070 |
Why?
|
Inpatients | 1 | 2018 | 2515 | 0.070 |
Why?
|
Cost-Benefit Analysis | 1 | 2019 | 5467 | 0.070 |
Why?
|
Environment | 1 | 2012 | 1115 | 0.060 |
Why?
|
Sepsis | 1 | 2019 | 2590 | 0.060 |
Why?
|
Cognition | 3 | 2021 | 6782 | 0.060 |
Why?
|
Intelligence | 1 | 2010 | 910 | 0.060 |
Why?
|
Decision Making | 1 | 2019 | 3856 | 0.060 |
Why?
|
Databases, Factual | 2 | 2018 | 7815 | 0.060 |
Why?
|
Cholecalciferol | 1 | 2010 | 538 | 0.060 |
Why?
|
Prospective Studies | 5 | 2013 | 53253 | 0.060 |
Why?
|
Dietary Proteins | 1 | 2010 | 939 | 0.060 |
Why?
|
Atrial Fibrillation | 1 | 2023 | 5052 | 0.060 |
Why?
|
Attitude of Health Personnel | 1 | 2018 | 3837 | 0.060 |
Why?
|
Muscle Strength | 1 | 2008 | 599 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2907 | 0.060 |
Why?
|
Confidence Intervals | 1 | 2010 | 2920 | 0.060 |
Why?
|
Healthcare Disparities | 1 | 2019 | 3226 | 0.060 |
Why?
|
Adult | 3 | 2022 | 215192 | 0.050 |
Why?
|
Propensity Score | 2 | 2021 | 1848 | 0.050 |
Why?
|
Quality of Life | 2 | 2021 | 12977 | 0.050 |
Why?
|
Physicians | 1 | 2021 | 4536 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2018 | 4868 | 0.050 |
Why?
|
RNA, Messenger | 3 | 2022 | 12767 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2020 | 19819 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15010 | 0.050 |
Why?
|
Acceleration | 1 | 2022 | 181 | 0.050 |
Why?
|
Vitamins | 1 | 2010 | 1611 | 0.050 |
Why?
|
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 1 | 2021 | 88 | 0.050 |
Why?
|
Analysis of Variance | 1 | 2010 | 6226 | 0.050 |
Why?
|
Antibodies, Viral | 2 | 2022 | 3074 | 0.050 |
Why?
|
Prevalence | 1 | 2017 | 15312 | 0.050 |
Why?
|
Regression Analysis | 1 | 2010 | 6334 | 0.040 |
Why?
|
Calcium | 2 | 2010 | 5656 | 0.040 |
Why?
|
National Institute on Aging (U.S.) | 1 | 2019 | 36 | 0.040 |
Why?
|
Immunization, Secondary | 1 | 2022 | 347 | 0.040 |
Why?
|
Anemia | 1 | 2009 | 1483 | 0.040 |
Why?
|
Cause of Death | 1 | 2010 | 3618 | 0.040 |
Why?
|
Vitamin D | 2 | 2010 | 3240 | 0.040 |
Why?
|
Maryland | 1 | 2019 | 267 | 0.040 |
Why?
|
Internship and Residency | 1 | 2019 | 5775 | 0.040 |
Why?
|
Administration, Topical | 1 | 2021 | 688 | 0.040 |
Why?
|
Australia | 1 | 2022 | 1214 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9522 | 0.040 |
Why?
|
Constipation | 1 | 2023 | 549 | 0.040 |
Why?
|
Depression | 2 | 2020 | 7826 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2019 | 127 | 0.040 |
Why?
|
Morbidity | 1 | 2023 | 1744 | 0.040 |
Why?
|
Practice Guidelines as Topic | 2 | 2018 | 7280 | 0.040 |
Why?
|
Sodium | 1 | 2023 | 1605 | 0.040 |
Why?
|
Mass Screening | 1 | 2013 | 5334 | 0.040 |
Why?
|
Patient Selection | 1 | 2010 | 4194 | 0.040 |
Why?
|
Canada | 1 | 2022 | 2089 | 0.040 |
Why?
|
Mortality | 1 | 2008 | 2854 | 0.040 |
Why?
|
Diarrhea | 1 | 2023 | 1327 | 0.030 |
Why?
|
Focus Groups | 1 | 2021 | 1338 | 0.030 |
Why?
|
Indians, North American | 1 | 2019 | 353 | 0.030 |
Why?
|
Coronary Disease | 1 | 2009 | 5928 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2021 | 843 | 0.030 |
Why?
|
Androgens | 1 | 2021 | 1276 | 0.030 |
Why?
|
Antibodies, Neutralizing | 1 | 2022 | 1897 | 0.030 |
Why?
|
Qualitative Research | 1 | 2022 | 2844 | 0.030 |
Why?
|
Delirium | 1 | 2024 | 1635 | 0.030 |
Why?
|
Patient Participation | 1 | 2021 | 1412 | 0.020 |
Why?
|
Hemorrhage | 1 | 2023 | 3521 | 0.020 |
Why?
|
Glucose | 1 | 2023 | 4304 | 0.020 |
Why?
|
Body Mass Index | 1 | 2008 | 12657 | 0.020 |
Why?
|
Recovery of Function | 1 | 2021 | 2924 | 0.020 |
Why?
|
Accidents, Home | 1 | 2010 | 72 | 0.020 |
Why?
|
Child | 1 | 2018 | 78492 | 0.020 |
Why?
|
Diet | 2 | 2023 | 7888 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2023 | 25184 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2022 | 3654 | 0.020 |
Why?
|
Patient Readmission | 1 | 2023 | 3178 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2019 | 2708 | 0.020 |
Why?
|
DNA Methylation | 1 | 2022 | 4259 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2384 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4730 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2009 | 15356 | 0.020 |
Why?
|
Health Status Indicators | 1 | 2012 | 959 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2012 | 2606 | 0.010 |
Why?
|
Telemedicine | 1 | 2021 | 2898 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2013 | 2688 | 0.010 |
Why?
|
Socioeconomic Factors | 1 | 2013 | 7685 | 0.010 |
Why?
|
Algorithms | 1 | 2009 | 13810 | 0.000 |
Why?
|
Concepts
(280)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(45)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_